5 results match your criteria: "Diskapi Yildirim Beyazit Training Hospital[Affiliation]"
Ulus Cerrahi Derg
May 2015
Clinic of General Surgery, Dışkapı Yıldırım Beyazıt Training Hospital, Ankara, Turkey.
Int J Infect Dis
May 2009
Diskapi Yildirim Beyazit Training Hospital, Ankara, Turkey.
Crimean-Congo hemorrhagic fever (CCHF) is an acute, tick-borne viral disease, with the potential for human to human transmission. Infection often has severe hemorrhagic manifestations and considerable mortality. Healthcare workers (HCWs) caring for patients with CCHF constitute a major risk group for infection.
View Article and Find Full Text PDFKnee Surg Sports Traumatol Arthrosc
September 2008
Anesthesiology and Reanimation Department, Diskapi Yildirim Beyazit Training Hospital, Ankara, Turkey.
In this study we have evaluated the post menisectomy pain relief offered by Saphenous nerve block. This study was planned on 40 patients with a pre-operative and post operative diagnosis of medial meniscus lesion undergoing partial menisectomy arthroscopically. Patients were randomized into 2 groups where Group I received a preoperative Saphenous block while group 2 did not receive a peripheral block, but received 1 ml of saline as placebo injection.
View Article and Find Full Text PDFEur J Dermatol
July 2008
Ministry of Health Dişkapi Yildirim Beyazit Training Hospital, Department of Dermatology, Ankara, Turkey.
Facial involvement in psoriasis receives little attention in standard descriptions of the disease. To our knowledge there has been only one comparison study on the severe of psoriasis between patients with and without facial involvement. The purpose of this study was to define the prevalence and characteristics of facial involvement, and to compare the severity of psoriasis between patients with and without facial involvement.
View Article and Find Full Text PDFPediatr Surg Int
June 2007
SB Diskapi Yildirim Beyazit Training Hospital, 2nd Urology Clinic, Irfan Bastug Cad. P.C. 06110, Diskapi/Ulus, Ankara, Turkey.
Dextranomer/hyaluronic acid (Dx/HA) copolymer has been used widely for the treatment of vesicoureteral reflux (VUR) in children since 2001. However, the factors that influence the outcome of injection therapy with Dx/HA have remained unclear. In this study, we retrospectively evaluated the outcomes in 101 consecutive children to determine the cure and to identify the factors that can impact treatment outcomes of Dx/HA injection.
View Article and Find Full Text PDF